Ox Capital Management forecasts that Chinese mid-cap stocks will thrive due to AI implementation, especially in healthcare.

From "fast-follow" to "first-in-class/best-in-class", Chinese R&D teams have repeatedly set new records in global clinical ...

Chinese mid-cap stocks will be the next winners as companies take advantage of advancements in artificial intelligence, ...

It takes courage to speak up in China, but not only have murmurs arisen, many are warning of what could go wrong if AI is ...

And yet, we have recently built systems that are smarter than people in many ways, and are able to significantly amplify the ...

A clinical trial led by London Health Sciences Centre Research Institute (LHSCRI) and Western University's Schulich School of ...

Artificial intelligence is not just another technology. It is a civilization-level innovation that will increasingly impact ...

FROM artificial intelligence to military defence, China has offered a few DeepSeek moments this year, showing that the ...

The portfolio continues to invest in companies we believe are strong and improving and have improvement that is sustainable.

The main findings of the study, published in Cell, were: The researchers identified 851 distinct N-acyl lipids across various ...

Three months after DeepSeek, a Chinese AI developer, shocked the tech world with a model that rivalled the best in ...

Each of these approaches can be explained another way as harnessing the capabilities of an existing AI model to assist in the ...